SGC

Business Context and Reporting Period

Company: Superior Group of Companies, Inc. (SGC)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 2026
Business Overview: The Company operates three segments: Branded Products (promotional products/uniforms), Healthcare Apparel (scrubs/medical apparel), and Contact Centers (business process outsourcing). The Company is an accelerated filer and a smaller reporting company.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Turnaround: The Company reported a net income of $0.8 million in Q1 2026, reversing a net loss of $0.8 million in Q1 2025. This improvement was driven by higher gross margins in Branded Products and Healthcare Apparel, and reduced interest expense.
• Revenue Growth: Consolidated net sales increased 2.8% year-over-year. Branded Products sales rose 5.1% and Healthcare Apparel sales rose 4.9%, offset by an 8.1% decline in Contact Centers due to client attrition.
• Margin Expansion: Consolidated gross margin rate improved to 37.1% from 36.8%. Branded Products margin rate increased to 34.1% due to favorable pricing mix, while Healthcare Apparel margin rate decreased slightly to 35.6% due to higher costs from lower-margin customers.
• Expense Management: Selling and administrative expenses remained relatively flat ($50.4 million vs. $50.1 million). Interest expense decreased 26.7% to $0.9 million due to a lower weighted average interest rate (4.9% vs. 5.4%).
• Cash Flow: Operating cash flow turned positive at $9.4 million, compared to a $2.0 million outflow in the prior year, primarily due to improved collections of receivables.

Guidance, Outlook, and Risks

• Management Commentary: Management attributes the Q1 2026 results to volume increases in branded uniforms and healthcare apparel. The Contact Centers segment continues to face headwinds from client attrition exceeding new acquisitions.
• Tariff and Trade Environment: The Company faces significant exposure to trade policies. In February 2026, the U.S. Supreme Court invalidated tariffs imposed under IEEPA, though a new 10% tariff under Section 122 of the Trade Act of 1974 was implemented. The Company recorded a $2.3 million duties receivable related to retroactive extensions of trade agreements (AGOA, HOPE, HELP) but has not recorded a refund receivable for invalidated IEEPA tariffs due to collection uncertainty.
• Capital Allocation: The Company paid $2.2 million in cash dividends and repurchased $0.7 million of common stock. A new 10b5-1 trading plan was entered into on March 20, 2026, to repurchase up to $2.5 million of shares.
• Risks: Key risks include global political instability (e.g., conflicts in the Middle East), supply chain disruptions in sourcing countries (China, Haiti, Vietnam), inflation, and the potential expiration of trade preferences beyond December 2026.

Investor Verification Checklist

• Tariff Refund Status: Verify the likelihood and timing of recovering tariffs paid prior to February 24, 2026, following the Supreme Court ruling, as no receivable has been recorded.
• Contact Centers Attrition: Assess the sustainability of the 8.1% revenue decline in the Contact Centers segment and the effectiveness of cost reduction measures implemented after the Jamaica office closure.
• Healthcare Apparel Margins: Monitor the impact of "lower margin existing customers" on the Healthcare Apparel segment's gross margin rate, which declined to 35.6%.
• Debt Covenants: Confirm continued compliance with the Credit Agreement's fixed charge coverage ratio (1.25:1) and net leverage ratio (4.0:1), especially given the reliance on revolving credit facilities.
• Trade Agreement Renewals: Track the status of AGOA, HOPE, and HELP agreements post-December 2026 to evaluate potential cost increases in sourcing from Africa and Haiti.